صنعتی کیمیدارو
دکیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/04/20 Fiscal Year 2025/12/2112 Month | 2025/04/09 Fiscal Year 2024/12/2012 Month | 2024/04/03 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 192.624 Billion | 985.405 Billion | 985.405 Billion | |
Trade Receivables | 9.596 Trillion | 6.686 Trillion | 7.644 Trillion | |
Prepayments | - | 1.163 Trillion | 1.213 Trillion | |
Orders & Prepayments | 429.799 Billion | - | - | |
Raw Materials & Packaging Inventory | 1.639 Trillion | 1.691 Trillion | - | |
Work-in-Progress Inventory | 189.386 Billion | 299.671 Billion | - | |
Finished Goods Inventory | 121.164 Billion | 765.368 Billion | - | |
Spare Parts Inventory | 193.556 Billion | 142.779 Billion | - | |
Goods in Transit | - | 718.399 Billion | - | |
Our Goods on Consignment with Others | 78.646 Billion | - | - | |
Other Inventories | -20.577 Billion | -20.792 Billion | 3.597 Trillion | |
Inventories | 2.201 Trillion | 3.597 Trillion | 3.597 Trillion | |
Total Current Assets | 12.42 Trillion | 12.431 Trillion | 13.44 Trillion | |
Long-Term Investments | 63.118 Billion | 293.462 Billion | 57.862 Billion | |
Long-Term Investments in Affiliates | 252.605 Billion | - | 235.6 Billion | |
Intangible Assets | 29.437 Billion | 9.591 Billion | 9.591 Billion | |
Other Assets | 142.625 Billion | - | - | |
Property, Plant & Equipment | 506.366 Billion | 434.398 Billion | 434.398 Billion | |
Net Fixed Assets | 506.366 Billion | 434.398 Billion | 434.398 Billion | |
Total Non-Current Assets | 994.151 Billion | 737.451 Billion | 737.451 Billion | |
Total Assets | 13.414 Trillion | 13.168 Trillion | 14.177 Trillion | |
Trade Payables | 3.532 Trillion | 2.612 Trillion | 2.612 Trillion | |
Advances Received | 39.078 Billion | 29.019 Billion | 29.019 Billion | |
Income Tax Provision | 156.76 Billion | 288.745 Billion | 288.745 Billion | |
Proposed & Payable Dividends | 1.896 Trillion | 1.999 Trillion | 1.999 Trillion | |
Current Borrowings | 4.469 Trillion | 5.435 Trillion | 5.435 Trillion | |
Total Current Liabilities | 10.092 Trillion | 10.364 Trillion | 10.364 Trillion | |
Employee Termination Benefits Provision | 729.914 Billion | 394.318 Billion | 394.318 Billion | |
Total Non-Current Liabilities | 729.914 Billion | 394.318 Billion | 394.318 Billion | |
Total Liabilities | 10.822 Trillion | 10.758 Trillion | 10.758 Trillion | |
Capital | 576 Billion | 576 Billion | 576 Billion | |
Retained Earnings | 1.959 Trillion | 1.802 Trillion | 2.812 Trillion | |
Legal Reserve | 57.6 Billion | 57.6 Billion | 57.6 Billion | |
Share Premium Reserve | -244 Million | -25.978 Billion | -25.978 Billion | |
Total Equity | 2.592 Trillion | 2.41 Trillion | 3.419 Trillion | |
Total Liabilities & Equity | 13.414 Trillion | 13.168 Trillion | 14.177 Trillion | |
Approved Capital | 576 Billion | 576 Billion | 576 Billion | |
Approved Retained Earnings | 1.383 Trillion | 1.021 Trillion | 1.948 Trillion | |
Approved Legal Reserve | 57.6 Billion | 57.6 Billion | 57.6 Billion | |
Total Approved Equity (at AGM) | 2.016 Trillion | 1.654 Trillion | 2.581 Trillion |